BUY
|
Original-Research: Semperit AG Holding - from NuWays AG
Classification of NuWays AG to Semperit AG Holding
Soft Q1 numbers // guidance confirmed Topic: Semperit released soft Q1 results which were burdened by persistent market headwinds, including weakened demand and US tariff uncertainty. However, Semperit is seen to be well positioned to benefit from an anticipated market recovery in H2’25e. Q1 sales declined by 13.8% yoy to € 152m (eNuW: € 157m) due to ongoing market challenges and project delays. Sales in SEA decreased by 19.7% yoy to € 86m mainly driven by market cyclicality and projects delays in the belting business. In contrast, SIA experienced a more moderate sales decrease of 4.7% to € 66m, attributed to softer overall demand. EBITDA decreased by 52% yoy to € 11.1m in Q1, leading to a 7.3% margin (-5.7pp yoy). The decline was largely attributable to lower sales volumes, which could not be fully covered by cost-saving measures. Personnel expenses decreased only slightly by 2% yoy due to wage inflation pressure and despite a 7.2% yoy reduction in the average headcount. Cost of materials increased by 1.7% yoy to € 76m, leading to a 50.1% cost ratio (+7.6pp yoy). This was partly driven by a 25% yoy price increase in natural rubber as well as a noticeably increase in butadiene prices, which is used in synthetic rubber production. Mixed order intake: A challenging macro environment and uncertainty from US tariffs led to investment reluctance among customers. However, after a difficult start into the year, demand improved already in March and April, exceeding last year’s figures. Order intake for hoses and profiles remained low. While hoses recovered slightly in March, profiles is seen to remain subdued at least in the short-term due to continued weakness in the construction industry. Orders in the Form business were above last year, mainly due to Mountain Applications, whereas demand in Belting was significantly lower yoy due to project postponements. Order intake for RICO was solid, thanks to a strong healthcare and food sector. FY guidance reiterated: Management confirmed its € 65-85m operating EBITDA guidance (eNuW: € 74m), as a recovery is expected for H2’25e. Thanks to strategic investments in recent years, Semperit in our view is well positioned to benefit from a potential market recovery, which could be supported by the announced € 500bn German special infrastructure fund. Reiterate BUY with a price target of € 18.20, based on DCF. You can download the research here: http://www.more-ir.de/d/32626.pdf For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
||||||||||||||||||||
2139096 16.05.2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.